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There  is  strong  evidence  that high yielding  dairy cows  are extremely  susceptible  to  infectious  diseases,
and  that  this  has severe  economic  consequences  for the  dairy  industry  and  welfare  implications.  Here
we  present  preliminary  functional  evidence  showing  that  the  innate  immune  response  differs  between
cow  breeds.  The  ability  of  macrophages  (MØ) to  kill  pathogens  depends  in part  on  oxygen-dependent  and
independent  mechanisms.  The  oxygen-dependent  mechanisms  rely  on  the generation  of  reactive  oxygen
and  nitrogen  species  (ROS/RNS,  respectively).  ROS  production  has  been  shown  to  activate  the  inﬂamma-
some  complex  in  MØ  leading  to increased  production  of  the pro-inﬂammatory  cytokine  Interleukin-1
(IL-1).  Conversely  RNS  inhibits  inﬂammasome  mediated  IL-1  activation,  indicating  a division  between
inﬂammasome  activation  and  RNS production.  In the present  study  MØ  from  Brown  Swiss  (BS) cattle
produce  signiﬁcantly  more  RNS  and  less  IL-1  when  compared  to  cells  from  Holstein  Friesian  (HF)  cattle
in  response  to bacterial  or fungal  stimuli.  Furthermore,  BS  MØ  killed  ingested  Salmonella  typhimurium
more  efﬁciently,  supporting  anecdotal  evidence  of increased  disease  resistance  of  the  breed.  Inhibition
of  autophagy  by 3-methyladenine  (3-MA)  stimulated  IL-1  secretion  in  cells  from  both  breeds,  but  was
more  pronounced  in  HF MØ.  Blocking  RNS  production  by  l-arginase  completely  abolished  RNS  production
but  increased  IL-1  secretion  in BS  MØ. Collectively  these  preliminary  data  suggest that the  dichotomy
of  inﬂammasome  activation  and  RNS production  exists  in cattle  and differs  between  these  two  breeds.  As
pattern  recognition  receptors  and signaling  pathways  are  involved  in  the assessed  functional  differences
presented  herein,  our  data  potentially  aid the  identiﬁcation  of  in  vitro  predictors  of  appropriate  innate
immune  response.  Finally,  these  predictors  may  assist  in  the  discovery  of  candidate  genes  conferring
increased  disease  resistance  for  future  use  in combination  with  known  production  traits.
© 2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
Macrophages (MØ) are the mature form of circulating
onocytes (Mo) derived from a common myeloid progenitor.
nﬂammatory cytokines trigger adherence and rolling of circulat-
ng Mo  along the endothelium of adjacent blood vessels before
xtravasation, maturation to MØ and migration to sites of inﬂam-
ation, where they have both pro-inﬂammatory and inﬂammationesolution activity (Aguilar-Ruiz et al., 2011; Cros et al., 2010;
ussen et al., 2013; Shi and Pamer, 2011; Wong et al., 2011, 2012).
n humans Mo  can be typiﬁed into three subsets based on the
∗ Corresponding author. Fax: +44 1707 666298.
E-mail address: dwerling@rvc.ac.uk (D. Werling).
ttp://dx.doi.org/10.1016/j.vetimm.2016.02.018
165-2427/© 2016 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
expression of CD14 and CD16: CD14++CD16−,  CD14++CD16+ and
CD14+CD16++. These are referred to as classical (cM), intermedi-
ate (intM) and non-classical (ncM), respectively (Ziegler-Heitbrock
et al., 2010). It has been indicated that the three subsets have dif-
ferent roles (Grage-Griebenow et al., 2001) and there may be a
developmental pathway from cM through intM to ncM (Wong et al.,
2011; Zawada et al., 2011). Exposure to the cytokine Macrophage-
Colony Stimulating Factor (M-CSF) may  trigger this development
(Korkosz et al., 2012).
In cattle, approximately 89% of monocytes are cM (Hussen
et al., 2013). These express greater phagocytic activity than intM
or ncM, whilst also producing anti-inﬂammatory cytokines such
as IL-10 (Grage-Griebenow et al., 2001; Ziegler-Heitbrock, 2007;
Ziegler-Heitbrock et al., 2010) and being involved in repair of dam-
age tissue (Wong et al., 2011, 2012). Both subsets of CD16+ Mo
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ncrease with infection and disease, extravasating more efﬁciently
nd producing cytokines including TNF and IL-1, thus being
escribed as inﬂammatory Mo  (Aguilar-Ruiz et al., 2011; Ancuta
t al., 2003; Belge et al., 2002; Grage-Griebenow et al., 2001; Tacke
nd Randolph, 2006; Thieblemont et al., 1995; Wong et al., 2012;
awada et al., 2011; Ziegler-Heitbrock et al., 2010), although some
ndings indicate anti-inﬂammatory actions for ncM (Cros et al.,
010; Hussen et al., 2013). A range of pro-inﬂammatory actions are
xhibited by murine and human intM, from inﬂammatory cytokine
roduction to antigen presentation, requiring prior phagocytosis
Aguilar-Ruiz et al., 2011; Belge et al., 2002; Shi and Pamer, 2011;
homas and Lipsky, 1994; Ziegler-Heitbrock, 2007).
Correlating with their role in antigen presentation, human intM
isplay the highest MHC  II expression levels of the three mono-
yte subsets (Wong et al., 2011), indicating a strong involvement
n antigen presentation. In addition to the production of cytokines
nd their function as antigen presenting cells, MØ constantly sam-
le the local environment and have antigen presenting capacity
Chesnut and Grey, 1985; Gordon, 1998; Gordon and Taylor, 2005).
Responses to pathogens by MØ are mediated by pattern recog-
ition receptors (PRR) such as Toll-like Receptors (TLR) which
ecognise and interact with pathogen associated molecular pat-
erns (PAMP) (Akira et al., 2001; Taylor and Gordon, 2003). PAMPs
nclude, but are not restricted to pathogen surface structures,
enetic material and secreted or released products (Taylor and
ordon, 2003). MØ are characteristically bactericidal in nature and
tilise several approaches to mediate bacterial killing but mainly
mploying two mechanisms which are closely interlinked: produc-
ion of reactive oxygen species and reactive nitrogen species (ROS
nd RNS, respectively). Their release results in cell- and DNA dam-
ge and thus shows antimicrobial effects (Bogdan, 2001; Forman
nd Torres, 2001; Nathan, 1992, 1987). Interaction of a PAMP with
he corresponding PRR stimulates a variety of pathways, resulting
n the activation with the subsequent cleavage of pro-IL-1 into its
ctive, secreted form by caspase-1 (Lamkanﬁ et al., 2007), assem-
ly of the NADPH oxidase complex, electron transfer from NADPH
o oxygen and a series of enzymatic reactions to produce ROS
Bokoch and Knaus, 2003; Lambeth, 2004; Quinn and Gauss, 2004).
dditionally, PAMP association with PRR results in transcription of
nducible Nitric Oxide Synthase (iNOS) in MØ  which interacts with
ADPH and ROS intermediates to create RNS in bovine and murine
Ø (Jungi et al., 1996a; Nathan, 1992; Green et al., 1990).
However, there are some infectious diseases where – due to
he anatomical barrier present – the anti-bacterial activity of MØ
s not sufﬁcient to eliminate the pathogen. One such organ is the
ovine udder, where mechanical, chemical and pathological irrita-
ion can lead to an increased somatic cell count (SCC) (Schukken
t al., 2003). However, it has to be emphasised that somatic cells
n the milk consist of a pleiotropha of cells, including MØ,  neu-
rophils, lymphocytes and epithelial cells (Boulanger et al., 2001).
n humans, the majority of cells in milk have been identiﬁed as
nique breast milk MØ  (Yagi et al., 2010). These have been shown
o be more metabolically active compared with those in periph-
ral blood (Johnson et al., 1980). However, the killing mechanism
as shown to involve the oxidation of glucose via the hexose-
onophosphate (HMP) shunt, showing that cytotoxic effects are
sing the same mechanism as blood derived cells by the produc-
ion of hydrogen peroxide and superoxide (Johnson et al., 1980).
ndeed, bovine mammary MØ challenged with phagocytic stimuli
roduced ROS similarly to those produced by other MØ (Harmon
nd Adams, 1987). Thus milk-derived MØ are capable of ROS/RNS
roduction, has been described in milk-derived MØ (Denis et al.,
006), and seems to be an approach of the innate immune cells to
ombat invading bacteria in the udder.
However, despite the fact that 1/4 of cows are suffering from
astitis at any given time, not all breeds show the same mastitis Immunopathology 181 (2016) 15–23
incidence rate (Begley et al., 2009). Indeed, cattle breed suscepti-
bility or resistance to infection has long been studied to improve
breeding strategies (Warner et al., 1987), and differences in the
genetic resistance to infection have been identiﬁed for Mycobac-
terium tuberculosis (O’Reilly and Daborn, 1995; Vordermeier et al.,
2012) and Brucellosis (Paixao et al., 2006).
However, it has to be emphasised that research results, espe-
cially analysis of immune responses, may  not translate between
breeds of the same species. Indeed, observations by farmers and
veterinarians have noted that Brown Swiss (BS) cattle tend to have
a lower somatic cell counts (SCC) than Holstein-Friesian (HF) cat-
tle, and are thought to be less susceptible to mastitis. This anecdotal
evidence has been reinforced by studies suggesting differences in
SCC could be the result of improved microbial killing mechanisms
in the innate cells of BS cattle (Busato et al., 2000; Kizilkaya, 2009;
Rupp and Boichard, 2003). Work by Norimatsu et al. (2004), show-
ing low RNS production from Salmonella typhimurium stimulated
HF MØ compared to data published by Werling et al. (2004) demon-
strating high RNS production from BS MØ with the same bacterium
highlights that difference in disease resistance may  be conferred by
the micro-bicidal capabilities of diverse breeds. Furthermore, work
by Jann et al. (2008, 2009) suggests that polymorphisms in TLR
genes may  be involved in disease resistance or susceptibility traits
in domestic animals (Jann et al., 2009, 2008). Despite estimations in
heritability of production traits varying (Rupp and Boichard, 2003),
Lund et al. (1994) have shown the estimated heritability of SCC to
be moderately high (Lund et al., 1994). This suggests the possibility
of integrating low SCC into breeding strategies, particularly if lower
SCCs in milk could be linked to an increased MØ killing ability.
2. Materials and methods
2.1. Sample collection
Blood for PBMC isolation and subsequent MØ generation was
collected by puncture of the jugular vein from clinically healthy HF
and BS cows housed at either the RVC Boltons Park Farm (Hert-
fordshire, UK) or at Cancourt Farm (Wiltshire, UK). Animals used
were age- and lactation-matched (2nd or 3rd lactation, respec-
tively), unless otherwise stated. All procedures were carried under
Home Ofﬁce Project licence which was approved by the College’s
Ethics and Welfare Committee. For biological assays, blood was
drawn into sterile glass vacuum bottles containing 10% Acid Citrate
Dextrose (ACD) as anticoagulant. For whole blood ﬂow cytometric
analysis, blood was collected from three cows of each breed into
10 ml  EDTA Vacutainers (Beckton Dickinson, Oxford, UK) by punc-
ture of the jugular vein. Whole milk was collected into sterile glass
bottles from individual cows housed at either farm. All assays were
performed in at least four breed matched pairs apart from bacterial
killing assays, blood MØ  NO induction and preliminary IL-1 stim-
ulations, milk derived responses which were performed in 3, 2 and
1 breed matched pairs, respectively.
2.2. Isolation peripheral blood mononuclear cells and generation
of macrophages
Peripheral blood mononuclear cells (PBMC) were isolated from
whole blood as previously described (Jungi et al., 1996b). Brieﬂy,
blood was  centrifuged at 700 × g for 20 min  before buffy coats
were removed and washed in citrate buffer. RBC lysis was  per-
formed using ammonium-chloride lysis buffer. Resultant cells were
suspended in RPMI media (Life Technologies, UK) before being
underlayed with Histopaque (d = 1.083 g l−1, Sigma–Aldrich, UK) to
isolate PBMCs by density centrifugation. PBMC were washed in PBS
and counted by Trypan blue exclusion then incubated in Teﬂon bags
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or 7 days at 37 ◦C and 5% CO2 at a concentration of 5 × 106 ml−1 in
Ø medium containing 10% FCS. To harvest MØ, Teﬂon bags were
laced in the fridge at 4 ◦C for 30 min  and agitated to loosen cells.
ells were washed three times in PBS at 300 × g for 10 min, before
ounting as described above.
.3. Determination of circulating monocyte populations
Mo  populations were determined as previously described with
odiﬁcations (Hubl et al., 2000). Brieﬂy Brieﬂy 50 l blood samples
ere labelled with 5 l mouse anti-human (mh) CD14 APC (AbD
erotec, UK), 5 l mh  CD16 FITC (AbD Serotec, UK) and 15 l mb
oLA-DR (clone CC108) labelled with PE-680 via Zenon labelling as
er manufacturer’s instructions. Isotype controls were prepared by
irect addition of 10 l Mouse IgG2a APC, 10 L Mouse IgG2a FITC
nd 20 l Mouse IgG1 labelled with PE-680 as above to 50 l of
hole blood. Antibodies were allowed to incubate at room tem-
erature for 20 min  in the dark. Red blood cells were lysed by
ddition of ammonium chloride lysis buffer for 10 min  as above
efore placing on ice. Remaining cells were washed in PBS (Gibco,
K) and suspended in FACSFlow (BD Biosciences, UK) for analy-
is. Samples were analysed by FACS Calibur (BD Biosciences, UK).
o populations were gated for the presence of BoLA-DR and CD14
o exclude platelets, lymphocytes and granulocytes. BoLA-DRhi or
D14+ populations were used to identify CD14+ and CD16+ popula-
ion proportions of cM,  intM and ncM. 50,000 events were recorded
er sample using Cell Quest (BD Biosciences, UK). Data were sub-
equently analysed using FCS Express 4 (DeNovo Software, USA).
.4. Isolation of bovine macrophages from milk
Whole milk samples were kept on ice for 10 min  prior
o centrifugation at 3000 × g for 5 min  at 4 ◦C. Residual fat
ayer was removed using a spatula and supernatant discarded.
ell pellets were re-suspended in PBS/0.125 M EDTA/TE buffer
10 mM—Tris–HCl–1 mM EDTA pH 7.6) and allowed to stand at
oom temperature for 10 min. Cells were washed twice in TE buffer
nd ﬁnally suspended in PBS (PAA Laboratories, UK) for counting
y Trypan blue exclusion as above.
.5. Measurement of ROS production
ROS was measured as described previously (Conejeros et al.,
011). Brieﬂy, production of ROS by MØ  was measured by
xidation of 2,7-dichloroﬂuorescein diacetate (DCFH-DA) to ﬂu-
rescent 2,7-dichloroﬂuorescein (DCFH). MØ  were harvested as
bove and adjusted to a concentration of 1 × 107 per condition in
BSS (Gibco) before the addition of stimuli (1 mg  ml−1 zymosan
Sigma); 2–5 g ml−1 PMA  (Sigma), 20 g ml−1 Listeria monocy-
ogenes (L.m.); 1 × 108 bacteria ml−1, Staphylococcus aureus (S.a.)
T398 or HBSS as a negative control). DCFH-DA probe (1 mg  ml−1)
as added at ﬁnal concentration of 100 g ml−1 before being incu-
ated in the dark at 37 ◦C for 15 min. 150 l aliquots were plated
n triplicate on a black 96-well plate (Corning, UK). RFU were
easured using a spectrophotometer (SpectraMax M2,  Molecular
evices, UK) at 485 nm excitation and 530 nm emission. Cells were
ncubated at 37 ◦C, 5% CO2 between readings in 15 min  intervals for
 two hour period.
.6. Measurement of NO production using griess reagents
Determination of NO concentration in cell supernatants was  car-
ied out using Griess reagents as previously described (Werling
t al., 2004). MØ were harvested as above and adjusted to 4 × 105
ells ml−1 in 2% FCS MØ medium and 8 × 104 cells added a ﬂat-
ottomed 96-well plate for 24 h at 37◦ C, 5% CO2. Adherent cells Immunopathology 181 (2016) 15–23 17
were washed with PBS after 24 h to remove contaminating lympho-
cytes. Stimulants were prepared in 200 l of 2% FCS MØ  medium
to give a ﬁnal concentration of 250 g ml−1 zymosan (Sigma, UK),
100 g ml−1 L.m., 5 g ml−1 LPS or media controls. MØ  were cul-
tured for a further 24 h 37◦ C, 5% CO2 and cell free supernatants
were harvested and stored at −20◦ C until required for measure-
ment of NO or cytokine analysis (IL-1). Brieﬂy, a two-fold standard
curve of 128 M sodium nitrite in 2% FCS MØ media and sam-
ple supernatants were placed in ﬂat 96-well clear plate and mixed
with equal volumes of Griess reagent (1:1 solutions A and B). After
10 min  incubation absorbance was  analysed at 550 nm using a spec-
trophotometer (Spectramax M2,  Molecular Devices, UK).
2.7. Inhibition of RNS production by l-arginase
MØ were generated and harvested as described above, adjusted
to 1 × 106 ml−1 in 2% FCS MØ  medium and 2 × 105 MØ were added
per well of 96-well plate and cultured as above. Adherent cells were
washed after 24 h twice with PBS before addition of 2% MØ media,
RNS inhibitor l-arginase (0.125 g ml−1) and Zymosan (1 mg  ml−1).
Supernatants were collected 24 h later and stored until analysis of
RNS and IL-1 production as described.
2.8. Inhibition of autophagy in macrophages with
3-methyladenine
MØ were generated and harvested as described above, adjusted
to 1 × 106 ml−1 in 2% FCS MØ  medium and 2 × 105 MØ were added
per well of 96-well plate and cultured as above. After removal of
contaminating lymphocytes and washing adherent cells twice in
PBS, MØ were exposed to LPS (5 g ml−1) (Sigma, UK) and two-fold
dilution of 3-methyladenine (3-MA) (Sigma, UK) from 10 mM to
1.25 nM,  including medium, LPS and 3-MA alone controls. MØ  were
cultured for a further 24 h at 37◦ C, 5% CO2 and cell free supernatants
harvested and stored at −20 ◦C until assayed for IL-1 by ELISA.
2.9. IL-1  ˇ detection by ELISA
Cell-free supernatants were stored at −20 ◦C until sandwich
ELISAs could be used to analyse cytokine production (IL-1) in
response to the ligand sets described (Zymosan, L. monocytogenes
and LPS). ELISA kit speciﬁc for boIL-1 (Thermo-Scientiﬁc, IL, USA)
was prepared using a Maxi-sorb 96-well ELISA plate (Nunc, Sigma,
UK) and performed according the manufacturer’s instructions.
Samples were tested in duplicate and standard curves were gen-
erated using a serial 1:2 dilution from 2 ng ml−1 IL-1. Samples
diluted 1:10 with reagent diluent were assayed alongside stan-
dards as per manufacturers instructions without modiﬁcations.
After ﬁnal addition of stop solution, absorbance was  measured at
450 nm with 550 nm reference using a spectrophotometer (Spec-
traMax M2,  Molecular Devices, UK).
2.10. Macrophage phagocytosis of S. aureus bio-particles
MØ were harvested as described above and adjusted to
1 × 106 ml−1 in RPMI 1640 medium without phenol red (Gibco,
UK) before placing 2 × 105 MØ per well of a 96 well U-bottomed
low bind plate (Costar, USA). MØ were exposed to S.a. BioParticles®
Alexa-594 (Life Technologies, UK) and were incubated at 37 ◦C and
5% CO2. At two different timepoints (0 and 60 min) 100 l of 4%
paraformaldehyde was added to ﬁx the cells and halt phagocyto-
sis. Cells were then washed three times in PBS (Gibco, UK)  and
suspended in FACS ﬂow for analysis. Samples were analysed by
FACS Calibur (BD Biosciences UK), data collected with Cell Quest
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Fig. 1. SCC, but not milk production or monocyte subset distribution differ between Brown Swiss and Holstein Friesian cattle.
SCC  was  assessed over a ﬁve year period. Data were provided by the National Milk Record, and an annual average of BS and HF animals on the farms is shown (Fig. 1A). In
contrast, average milk production (Fig. 1B) as well as composition of Mo  subsets (Fig. 1C) was not statistically different. Whole blood from BS and HF cattle were labelled
with  antibodies directed to human CD14:APC, human CD16:FITC and bovine HLA-DR: PE-680 alongside isotype controls as described. Cells were visualised post RBC lysis and
washing using BD FACS Calibur, recording 50,000 events per sample with Cell Quest. Mo subsets were gated from HLA-DRhi and CD14+ cells to identify cM (CD14++/CD16−),
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tatistical analysis. Differences between breeds were tested by one-way ANOVA, fo
ro (BD Biosciences, UK) and subsequently analysed using FlowJo
10 (Treestar, USA).
.11. Preparation of S. typhimurium cultures
S. typhimurium SL1344 was inoculated onto LB agar and incu-
ated at 37 ◦C for 16–18 h before storing at 4 ◦C as a source for
uture liquid cultures. On the day prior to each MØ infection, a new
noculum was created from a single colony in 10 ml  sterile LB broth
Oxoid, UK) and cultured overnight at 37 ◦C for 16–18 h with agita-
ion at 180 rpm. Cultures were centrifuged for 10 min  at 3219 × g,
1 ◦C and suspended in RPMI to generate an OD600 reading between
.8–1.0 (the equivalent of 108–109 CFU). Conﬁrmation of CFU was
etermined by 10-fold serial dilutions of overnight culture plated
nto LB agar, cultured overnight at 37 ◦C and counted.
.12. Infection of macrophages with S. typhimurium
MØ  were generated and harvested as described above, adjusted
o 1 × 105/1 × 106 MØ ml−1 in antibiotic free 2% FCS MØ medium
nd seeded at 1 × 105/1 × 106 per well of 24-well plate for 24 h
7 ◦C, 5% CO2. Contaminating lymphocytes were removed and cells
ere washed in PBS prior to inoculation with an MOI  of 10 for 1 h
t 37 ◦C, 5% CO2. After 1 h incubation RPMI supplemented with 10%
CS and 50 mg  ml−1 Gentamicin was added to eliminate extracellu-
ar bacteria and cells were incubated overnight at 37 ◦C, and 5% CO2.
upernatants were collected after 1 h and MØ were washed with
BS before addition of culture medium for a further 24 h of culture
t 37 ◦C, and 5% CO2. Supernatants were harvested and MØ weresed by FCS Express 4 and population proportions exported to GraphPad Prism for
 by Bonferroni t-test (*** p < 0.001)
washed with PBS prior to lysis using PBS +1% Triton X for 5 min.
Supernatants from 1 h, 24 h and MØ  lysis were serially diluted 10-
fold before plating on LB agar for 24 h at 37 ◦C to determine bacterial
uptake and killing.
2.13. Statistical analyses
Statistical analyses were performed using GraphPad Prism 6
using one-way ANOVA or two-way ANOVA (repeated measures for
ROS assays) with Bonferroni post-hoc testing. Unpaired t-tests were
used for analysis of bacterial killing with Bonferroni post-hoc test-
ing. Signiﬁcance was deﬁned as p ≤ 0.05 (*), p ≤ 0.01 (**), p ≤ 0.001
(***) and p ≤ 0.00001 (****).
3. Results
3.1. SCC, but not milk production or monocyte subsets differ
between cells isolated from both breeds
Initially, it was  assessed whether the above mentioned “resis-
tance” to mastitis in BS compared to HF was purely based on
differences in milk production, SCC or the number/composition
of Mo  subsets in the peripheral blood. Whereas SCC of BS cows
was signiﬁcantly lower over a one year period (Fig. 1A), neither
milk production (Fig. 1B) nor number/composition of Mo  subsets
(Fig. 1C), as analysed by ﬂow cytometry differed between HF and
BS cows.
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Fig. 2. Ex-vivo blood derived macrophages from Brown Swiss cattle differentially produce ROS and RNS compared to Holstein Friesian macrophages.
MØ  were generated as described from BS and HF PBMC isolated from whole blood. ROS production was  measured from MØ exposed to (A) L. monocytogenes (1 × 108 bacteria
ml−1) and (B) zymosan (1 mg  ml−1), by addition of DCFH-DA at 15 min  intervals over 120 min  period as relative ﬂuorescent units. Cells were maintained at 37 ◦C, 5% CO2
throughout. Fluorescence was detected using SpectraMax M2  plate reader in black, glass bottomed micro-titre plates. RNS production was  measured using Griess assay on
overnight macrophage culture supernatant from both cattle breeds. Adhered MØ were exposed to (C) 2% medium, L. monocytogenes (100 g ml−1), zymosan (250 g ml−1)
and  LPS (5 g ml−1) for 24 h before addition of equal volumes of Griess reagent A and B and compared to 2-fold Nitrite standard curve. Absorbance was  measured using a
SpectraMax M2  plate reader. All data were post analysed with GraphPad Prism using two-way repeated measured ANOVA (ROS) with Bonferroni post-hoc correction and
two-way non-repeated measures ANOVA (NO) with Bonferronic post-hoc testing.
Fig. 3. Milk resident cells mirror ex-vivo blood derived macrophage responses: Brown Swiss cattle produce more ROS Holstein Friesian macrophages.
MØ  from milk were isolated as described from BS and HF cattle, ROS was measured from MØ exposed to (A) S. aureus (1 × 108 ml−1) and (B) Zymosan (1 mg  ml−1) by addition
addition of DCFH-DA at 15 min  intervals over 120 min  period. Cells were maintained at 37 ◦C, 5% CO2 throughout. Fluorescence was detected using SpectraMax M2 plate
reader  in black, glass bottomed micro-titre plates. All data were post analysed with GraphPad Prism using two-way repeated measures ANOVA testing with Bonferroni
post-hoc  correction.
20 A.J. Gibson et al. / Veterinary Immunology and Immunopathology 181 (2016) 15–23
Fig. 4. NO blockade partially restores IL-1 Brown Swiss levels to those similar to Holstein Friesian macrophages.
MØ  derived from PBMC isolated from BS and HF cattle were adhered overnight and stimulated with 2% medium or (A) LPS (5 g ml−1) for 24 h. Supernatants were collected
and  analysed for bovine IL-1 by ELISA. Absorbance was measured using a SpectraMax M2 plate reader. RNS was inhibited in MØ cultures from (B) BS and (C) HF  with
l-arginase in the presence of Zymosan (1 mg ml−1) for 24 h after adherence of MØ.  Bovine IL-1 levels were determined by ELISA and RNS by addition of equal volumes of
Griess  reagent A and B and compared to 2-fold Nitrite standard curve. Absorbance was  measured for both assays using a SpectraMax M2  plate reader. All data were post
analysed with GraphPad Prism using two-way non-repeated measures ANOVA testing with Bonferroni post-hoc correction.
Fig. 5. Autophagy inhibition increases LPS induced IL-1 secretion from both Brown Swiss and Holstein Friesian macrophages.
3MA inhibits autophagy by blocking autophagosome formation via the inhibition of type III Phosphatidylinositol 3-kinases (PI-3 K), leading to a down-regulation of inﬂam-
maosome activation, and thus IL-1 production. To assess whether MØ of both breeds have the capability to respond with IL-1 production to inﬂammasome activation, MØ
were  derived from PBMC isolated from (A) HF and (B) BS and adhered overnight prior to inhibition of autophagy with 3MA  (from 10 mM to 1.25 mM)  in the presence of LPS
(5  g ml−1) for 24 h. Supernatants were collected and analysed for bovine IL-1 by ELISA. Absorbance was measured using a SpectraMax M2 plate reader. All data were post
analysed using GraphPad Prism using two-way non-repeated measures ANOVA with Bonferroni post-hoc testing.
Fig. 6. Phagocytosis is enhanced in Brown Swiss macrophages compared to Holstein Friesian macrophages.
(A)  MØ derived from PBMC isolated from BS and HF cattle were incubated with Alexa-594 labelled S.a bioparticles for up to 60 min  before ﬁxing with 4% PFA to suspend
phagocytosis. Cells were analysed with BD FACS Calibur recording 10,000 events using Cell Quest Pro. Data are presented corrected against MFI at 0 min  and post analysed
with  FlowJo v10 and GraphPad Prism using unpaired students t-test with Bonferroni post-hoc correction applied. (B) MØ  were derived from PBMC isolated from BS and HF
and  adhered overnight prior to exposure to S. typhimurium (10CFU) for 1 h. Supernatants were collected, cells were washed and culture was continued in the presence of
Gentamycin for 24 h. Supernatants (1 h and +24 h) and lysed MØ preparations where serially diluted 10-fold and plated for counting. Data were collated and post analysed
using  GraphPad Prism using unpaired students t-test with Bonferroni post-hoc testing.
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.2. Ex-vivo blood derived macrophages from Brown Swiss cattle
ifferentially produce ROS and NO compared to Holstein Friesian
acrophages
Having established that the potential differences between BS
nd HF cows are not due to differences in milk production (and
hus potentially less cells available) or differences in Mo  subsets
etween both breeds, we next assessed direct anti-bacterial effec-
or functions of matured MØ.  Oxidative burst was found to be
levated in BS MØ  exposed to L.m. and zymosan when compared
o HF (Fig. 2A and B). ROS were produced in signiﬁcantly greater
mounts from 60 min  post-stimulation for the duration of the assay
to 120 min). Reactivity appears to be stimulation speciﬁc and not
n overall ‘hyper’ or constitutive activity as MØ from both breeds
espond similarly to media or PMA  controls (data not shown). Inter-
stingly differences in NO production are less apparent towards
he same ligands from the animals tested here, however BS MØ
esponses show reduced variation (Fig. 2C). Having established dif-
erences in ROS/NOS production to the same ligand in MØ derived
rom both breeds, we next wanted to assess whether these differ-
nces also exist in MØ derived from other tissues.
.3. Milk resident cells mirror ex-vivo derived macrophage
esponses: Brown Swiss cattle produce more ROS Holstein Friesian
acrophages
A comparison of ROS production from milk derived cells
evealed enhanced responses from cells derived from BS cattle
hen stimulated with S.a. and zymosan as compared to cells
erived from, HF cattle (Fig. 3A and B). Increased levels of ROS
bserved for BS cells is not attributed to increased SCC as over the
tudy period HF milk contained signiﬁcantly greater somatic cells
Fig. 1A) and equal cell concentrations where stimulated per breed.
.4. RNS blockade partially restores IL-1  ˇ Brown Swiss levels to
hose similar to Holstein Friesian macrophages
Having established that MØ and milk-derived cells from BS cows
eem to produce more ROS/RNS compared to cells derived from HF
ows, we next wanted to establish whether this increased reactiv-
ty is a general sign for an increased innate immune response in BS
erived cells, and extends to other mediators of the innate immune
esponse, such as production of IL-1. Interestingly, stimulation of
Ø  derived from HF, but not BS cows with LPS resulted in increased
mounts of IL-1 in the supernatant (Fig. 4A). Recently, a link
etween NOS and activation of the inﬂammasome was  described
Mao  et al., 2013; Mishra et al., 2013), indicating that production
f RNS inhibits inﬂammasome activation. To assess whether such
echanism may  also account for the reduced ability of BS MØ to
roduce IL-1 in response to LPS, we next inhibited RNS production
sing l-arginase (Garvey et al., 1997), which converts arginine into
rnithine and urea, thus removing the substrate of iNOS. Indeed,
nhibition of RNS production by addition of l-arginase partially
estored the ability of BS MØ to produce IL-1 (Fig. 4B) indicat-
ng that activation of the inﬂammasome is potentially impaired
ue to high ROS/RNS production. In contrast, no effect was seen
hen using HF MØ (Fig. 4C), which was potentially due to the low
roduction of RNS in the ﬁrst instance by these cells.
.5. Autophagy inhibition increases LPS induced IL-1  ˇ secretion
rom both Brown Swiss and Holstein Friesian macrophagesInﬂammasome activation and autophagy are thought to be two
utual exclusive processes within cells (Harris, 2011), and inhibi-
ion of autophagy has been described to increase inﬂammasome
ctivation, resulting in increased IL-1 release (Harris, 2011). To Immunopathology 181 (2016) 15–23 21
further assess whether BS MØ have a generally impaired IL-1
production, autophagy was blocked in MØ  of both breeds before
cells were stimulated. As seen before, stimulation of MØ of either
breed with LPS alone induced very little increase in IL-1 secretion
compared to negative controls. Inhibition of autophagy before LPS
stimulation increased IL-1 secretion by MØ from both breeds in
a dose-dependent manner (Fig. 5A and B). However, the effect was
more pronounced in HF MØ  (Fig. 5C).
3.6. Phagocytosis and bacterial killing is enhanced in Brown
Swiss macrophages compared to Holstein Friesian macrophages
As the increased production of ROS/RNS by BS MØ  potentially
indicated a greater anti-bacterial response, we ﬁnally assessed
whether these differences could be attributed to phagocytic activ-
ity and bacterial killing. To do so, MØ of both breeds were assessed
their ability to phagocytose S.a. bio-particles. After 60 min  BS MØ
engulfed more bio-particles compared to HF MØ,  after normal-
isation to background phagocytosis (Fig. 6A). Lastly, we  aimed
to investigate whether all the parameters analysed increased the
capability of BS MØ to kill bacteria. Therefore, MØ from both breeds
were co-cultured with S. typhimurium and bacterial killing deter-
mined by recovered bacterial growth as described. Signiﬁcantly
fewer bacteria survived in BS MØ  compared to HF MØ  cows after
24 h of culture post-bacterial incubation (Fig. 6B).
4. Discussion
In the present study, we  examined potential functional differ-
ences to investigate anecdotal evidence suggesting BS cows are
more resistant to bacterial infection compared to HF cows. We
initially concentrated on the production and release of direct anti-
bactericidal effectors indicative of oxidative burst and production
of nitrogen species: ROS and RNS. Differences which we observed
in blood derived cells were also mirrored in milk derived cells,
leading us to investigate other immune parameters; production of
pro-inﬂammatory cytokine and indicator of inﬂammasome activa-
tion, IL-1, effects of RNS on IL-1 production, the ability of MØ
from both breeds to phagocytose and ﬁnally the capacity of MØ to
exert bactericidal effects on live bacteria.
An intriguing picture has emerged from this work, indicating
that there is some functional evidence to support anecdotal dif-
ferences between BS and HF cattle. Finding that BS MØ  or milk
derived MØ produce more ROS in response to the same stimula-
tion compared to HF MØ  indicates that differences between breeds
may  be reﬂected at the genetic level. Cattle breed resistance to
infectious disease is not a new concept, there are descriptions
detailing speciﬁc breed or traits for protection against infection
with Mycobacterium bovis and Brucella spp. (O’Reilly and Daborn,
1995; Paixao et al., 2006; Vordermeier et al., 2012). Indirectly
there are reports that BS and HF cattle respond differently to
S. typhimurium in the production of free radicals; a study by
Norimatsu et al. (2004) found HF MØ  to be non-responsive how-
ever an independent study by Werling et al. (2004) showed BS MØ
to produce high levels of RNS. We  also observed greater ROS and
RNS production from BS MØ with cells derived from age and lacta-
tion matched HF cows to help negate location, herd, and husbandry
and pregnancy status differences not accounted for by the earlier
studies.
We also examined the production of the pro-inﬂammatory
cytokine, IL-1, as a marker of inﬂammasome activation. We
observed that HF MØ produce higher IL-1 levels compared to
those derived from BS cows.
Making use of recent links between RNS, autophagy and IL-
1 secretion, blocking both RNS and autophagy modulated IL-1.
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nhibition of autophagy by means of 3MA  treatment exerted a
ose-dependent increase in IL-1 production in both cattle breeds;
owever the blockade of RNS synthesis by depletion of l-arginine
llowed a recovery or restoration of IL-1 responses in BS MØ
nly. These data suggest that RNS synthesis and associated neg-
tive feedback on IL-1 production may  be more efﬁcient in BS
attle. Additionally it appears that autophagy plays a similar role
n the inhibition of inﬂammasome mediated IL-1 cleavage and
elease in both breeds, based on that MØ  derived from BS and HF
ows responded equally to 3MA  blockade.
On determining these differences in secreted or released
olecules upon stimulation of MØ  derived from both cattle breeds,
e sought to identify if these disparities followed through to bac-
erial killing. Mo  subsets were found to be similar between breeds,
et S.a. bio-particle uptake was greater for BS MØ compared to HF
Ø.  Furthermore, BS MØ were better able to destroy live bacteria
s demonstrated by decreased S. typhimurium survival rates after
xposure to MØ from both breeds.
Our study examines several aspects of innate immune activation
nvolved in bactericidal effects where BS MØ consistently out-
erformed HF counterparts. We  postulate that these differences
ay  be explained at the genetic level and governed by genes which
irectly affect recognition and uptake of bacteria; PRR such as C-
ype Lectins or TLRs, those involved in the production of ROS and
NS and ﬁnally genes pertaining to the activation of the inﬂamm-
ome and IL-1 cleavage. Indeed, if such genetic differences would
e identiﬁed, our assays would provide means to link genotypes
ith phenotypes by relatively easy to perform and cost-effective
ssays. Previous studies have suggested that polymorphsims on
LR genes may  confer disease susceptibilities or resistance (Jann
t al., 2009, 2008), thus future studies might be best placed to
nvestigate both functional and genetic differences. Our ﬁnding that
S cattle were consistently lower over the study period for SCC
etected in milk and were better able to kill live bacteria warrants
urther investigation as a trait indicative of increased immune func-
ion, irrespective of breed, and would potentially help to explain
nﬂammation responses in different breeds. Indeed, some of these
esponses may  be perpetuated or made more severe via a pro-
onged, “false” innate immune response, leading to increased tissue
amage. Thus, it would perhaps be pertinent to include such
mmune function traits in combination with known production
arameter traits to improve existing dairy and beef herd stocks in
heir genetic resistance to (bacterial) infection. Most importantly
owever, our data clearly show that analysis of immune responses
ay  not be translated between breeds of the same species, and this
hould be kept in mind when assassing responses to pathogens as
ell as to vaccines.
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